Business Association Chemistry Pharma Life Sciences
Dossiers - Relations with the EU

Overview and position on relations with the EU

Dossiers - Relations with the EU

25 years of bilateral agreements: a model of success for Switzerland

Dossiers - Relations with the EU

Guest article Allnews: Director Stephan Mumenthaler

Dossiers - Relations with the EU

Full association to Horizon Europe essential

Dossiers - Relations with the EU

Interview by NZZ: Matthias Leuenberger, President scienceindustries

Dossiers - Relations with the EU

30 Years EU Single Market: Significance for Switzerland

Dossiers - Relations with the EU

What happens after the failed negotiations on the (InstA)?

Publications - Press releases

The knowledge nation of Switzerland needs the EU research programmes

Dossiers - Antibiotic resistance

Action plan: One Health approach to combating antimicrobial resistance

Dossiers - Antibiotic resistance

Overview and position on antibiotic resistance

Dossiers - Antibiotic resistance

Promoting research into new antibiotics - but how?

Dossiers - Antibiotic resistance

Containing resistances: Antibiotic monitoring in veterinary medicine

Dossiers - Chemicals regulation / PFAS

PFAS regulation in Switzerland: Not faster, but better

Dossiers - Chemicals regulation / PFAS

PFAS: Key facts at a glance

Dossiers - Chemicals regulation / PFAS

PFAS regulation in Switzerland: Learning from European experiences

Dossiers - Chemicals regulation / PFAS

PFAS - regulating important chemicals on a scientific basis

Close
Industry ticker

Newsletter subscription

scienceindustries News
Standpoints
Point
 
 

Foreign trade statistics chemistry pharma life science

Further analyzes

Export Chemicals Pharma Life Sciences Switzerland by region

Further analyzes